As shown in table 1, we found that downregulated ARHGAP25 expression was significantly correlated with aggressive tumor characteristics, including tumor size (P=0.012) and T stage (P=0.036), but not with age, gender, tumor grade, and N stage. This evidence concerns the gene ARHGAP25 and neoplasm.